PRISM-eBT
Primary standards and traceable measurement methods for X-ray emitting electronic brachytherapy devices
Informazioni Generali
- Coordinatore:
- PTB PHYSIKALISCH TECHNISCHE BUNDESANSTALT (Germania)
- Responsabile:
- PINTO MASSIMO - NUC-INMRI (CASACCIA)
- Ruolo ENEA:
- PARTNER
- Sito WEB:
- http://www.ebt-empir.eu/
Programmi Europei
- Programma:
- Other programmes -> EMPIR (N/A - Non applicabile)
Descrizione e Attività
Descrizione Generale
Electronic brachytherapy (eBT) targets tumours using X-rays from close range and has potential advantages over conventional radiotherapies. However, the systems available tend to have unique calibration methods; mostly indirect and with uncertainties larger than clinically acceptable. This means that treatment plans aren’t easily adapted from one system to another, impeding progress other therapy in clinical practice.
This project will deliver harmonised, simplified and traceable dosimetry for eBT detectors and measurement devices, by determining 3D dose distributions in water models. Four primary standards will be developed for absorbed doses from internal radiotherapy devices, new measurement methods will be developed, and guidance produced. The outcome will be a harmonised calibration service, capable of promotion to the profession, plus calibration standards for independent and traceable veri?cation of dosimetry, for both novel systems and for quality assurance of existing equipment. Comparability, backed by the first ever standards, will improve clinical confidence and, since treatment costs are lower than for conventional radiotherapies, increased uptake could reduce costs for Europe’s health systems.
Attività svolta da ENEA
L'ENEA coordina uno dei quattro work packages tecnici previsti, il WP1: campioni primari e di trasferimento per il rateo di dose assorbita in acqua alla profondità di 1 cm in acqua, dovuta a dispositivi EBT, con lo scopo di effettuare ricerche pre-normative necessarie per armonizzare e semplificare le procedure dosimetriche per l'uso clinico di eBT nella radioterapia interna, al fine di ridurre le incertezze nella determinazione della dose al livello raccomandato dall'AIEA.
Dati Finanziari (in euro)
Costo Eleggibile
Contributo
Durata del Progetto
Partner (8)
Keyword CORDIS (6)
Altre Keyword (0)
Nessuna altra keyword disponibile
2021 - Amendment proroga il progetto al 31 dicembre 2022 (durata 42 mesi).